Prognostic model based on six feature genes of intestinal flora subtypes predicts survival in colon cancer

References

• Ahmed M. 2020. Colon cancer: A clinician’s perspective in 2019. Gastroenterol Res. 13:1–10.
   PubMed Web of Science ®Google Scholar
• Amsellem S, Pflumio F, Bardinet D, Izac B, Charneau P, Romeo PH, Dubart-Kupperschmitt A, Fichelson S. 2003. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med. 9:1423–1427.
   PubMed Web of Science ®Google Scholar
• Bellemare-Pelletier A, Tremblay J, Beaulieu S, Boulassel MR, Routy JP, Massie B, Lapointe R, Thibodeau J. 2005. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. J Leukocyte Biol. 78:95–105.
   PubMed Web of Science ®Google Scholar
• Borst J, Ahrends T, Bąbała N, Melief CJM, Kastenmüller W. 2018. CD4(+) t cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 18:635–647.
   PubMed Web of Science ®Google Scholar
• Brown KGM, Koh CE. 2020. Surgical management of recurrent colon cancer. J Gastrointest Oncol. 11:513–525.
   PubMed Web of Science ®Google Scholar
• Bürtin F, Mullins CS, Linnebacher M. 2020. Mouse models of colorectal cancer: past, present and future perspectives. World J Gastroenterol. 26:1394–1426.
   PubMed Web of Science ®Google Scholar
• Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D. 2017. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer. 5:53.
   PubMed Web of Science ®Google Scholar
• Caprara G, Allavena P, Erreni M. 2020. Intestinal macrophages at the crossroad between diet, inflammation, and cancer. Int J Mol Sci. 21:4825.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang Y, Parra E, Rodriguez J, Behrens C, Akbani R, Lu Y, Kurie JM, Gibbons DL, Mills GB, et al. 2017. Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. 36:1384–1393.
   PubMed Web of Science ®Google Scholar
• Cui Q, Zhang Y, Su J, Shi C, Lei N, Ding K, Li J, Yu R, Wang L, Wang N. 2010. The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users. J Biomed Res. 24:374–380.
   PubMedGoogle Scholar
• Denny WA, Flanagan JU. 2021. Small-molecule CSF1R kinase inhibitors; review of patents 2015-present. Expert Opin Ther Patents. 31:107–117.
   PubMed Web of Science ®Google Scholar
• Gao X, Chen D, Hu X, Zhou Y, Wang Y, Wu C, Chen J, Wang Y, Pei R, Chen X. 2018. PLA1A participates in the antiviral innate immune response by facilitating the recruitment of TANK-binding kinase 1 to mitochondria. J Innate Immun. 10:315–327.
   PubMed Web of Science ®Google Scholar
• Garrett WS. 2019. The gut microbiota and colon cancer. Science. 364:1133–1135.
   PubMed Web of Science ®Google Scholar
• Granier C, Karaki S, Roussel H, Badoual C, Tran T, Anson M, Fabre E, Oudard S, Tartour E. 2016. Cancer immunotherapy: rational and recent breakthroughs. La Revue de Medecine Intern. 37:694–700.
   PubMed Web of Science ®Google Scholar
• Hu Y, Le Leu RK, Christophersen CT, Somashekar R, Conlon MA, Meng XQ, Winter JM, Woodman RJ, Mckinnon R, Young GP. 2016. Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcinogenesis. 37:366–375.
   PubMed Web of Science ®Google Scholar
• King MHH, Kr D, Ec D, Ma B, Ed C, Frey A. 2020. The link between fusobacteria and colon cancer: a fulminant example and review of the evidence. Immune Netw. 20:e30.
   PubMed Web of Science ®Google Scholar
• Li QCL, Tian Y, Zhang P, Ding C, Lu W, Jia C, Shao C, Liu W, Wang D, Ye H, Hao H. 2018. Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and metabolic reprogramming. Mol Cell Proteomics. 17:1531–1545.
   PubMed Web of Science ®Google Scholar
• Mcnabney SM, Henagan TM. 2017. Short chain fatty acids in the colon and peripheral tissues: A focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients. 9:1348.
   PubMed Web of Science ®Google Scholar
• Medina AM, Zubero EE, MaA J, SaA B, CaL G, Ramos JJG, Gutierrez JFS, Castillo ZG. 2018. NOS3 polymorphisms and chronic kidney disease. Jornal Brasileiro de Nefrologia: ‘Orgao Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia. 40:273–277.
   PubMedGoogle Scholar
• Mori G, Rampelli S. 2018. Shifts of faecal microbiota during sporadic colorectal carcinogenesis. Sci Rep. 8:10329.
   PubMed Web of Science ®Google Scholar
• Murata M. 2018. Inflammation and cancer. Environ Health Prevent Med. 23:50.
   PubMed Web of Science ®Google Scholar
• O'keefe SJ. 2016. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 13:691–706.
   PubMed Web of Science ®Google Scholar
• Orangio GR. 2018. The economics of colon cancer. Surg Oncol Clin North Amer. 27:327–347.
   PubMed Web of Science ®Google Scholar
• Pushpanathan P, Mathew GS, Selvarajan S, Seshadri KG, Srikanth P. 2019. Gut microbiota and its mysteries. Ind J Med Microbiol. 37:268–277.
   PubMed Web of Science ®Google Scholar
• Ruan H, Leibowitz BJ, Zhang L, Yu J. 2020. Immunogenic cell death in colon cancer prevention and therapy. Mol Carcinogen. 59:783–793.
   PubMed Web of Science ®Google Scholar
• Russo A, Saide A, Cagliani R, Cantile M, Botti G, Russo G. 2016. Rpl3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment. Sci Rep. 6:38369.
   PubMed Web of Science ®Google Scholar
• Sears CL. 2018. The who, where and how of fusobacteria and colon cancer. eLife. 7:e28434.
   PubMed Web of Science ®Google Scholar
• Sears CL, Garrett WS. 2014. Microbes, microbiota, and colon cancer. Cell Host Microbe. 15:317–328.
   PubMed Web of Science ®Google Scholar
• Song M, Chan AT, Sun J. 2020. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. 158:322–340.
   PubMed Web of Science ®Google Scholar
• Sun YL, Zhang Y, Guo YC, Yang ZH, Xu YC. 2020. A prognostic model based on six metabolism-related genes in colorectal cancer. BioMed Res Intern. 2020:5974350.
   PubMed Web of Science ®Google Scholar
• Teichweyde N, Kasperidus L, Carotta S, Kouskoff V, Lacaud G, Horn PA, Heinrichs S, Klump H. 2018. HOXB4 promotes hemogenic endothelium formation without perturbing endothelial cell development. Stem Cell Rep. 10:875–889.
   PubMed Web of Science ®Google Scholar
• Temraz SNF, Nasr R, Charafeddine M, Mukherji D, Shamseddine A. 2019. Gut microbiome: A promising biomarker for immunotherapy in colorectal cancer. Intern J Mol Sci. 20:4155.
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. 2012. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 10:575–582.
   PubMed Web of Science ®Google Scholar
• Wampach L, Heintz-Buschart A. 2018. Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential. Nat Commun. 9:5091.
   PubMed Web of Science ®Google Scholar
• Wang J, Hussain SP. 2017. NO(•) and pancreatic cancer: A complex interaction with therapeutic potential. Antioxid Redox Signal. 26:1000–1008.
   PubMed Web of Science ®Google Scholar
• Wieczorska K, Stolarek M, Stec R. 2020. The role of the gut microbiome in colorectal cancer: where are we? where are we going? Clin Colorectal Cancer. 19:5–12.
   PubMed Web of Science ®Google Scholar
• Yang G, Liu S, Maghsoudloo M, Shasaltaneh MD, Kaboli PJ, Zhang C, Deng Y, Heidari H, Entezari M, Fu S, et al. 2021. PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer. Sci Rep. 11:6056.
   PubMed Web of Science ®Google Scholar
• Zhang X, Han J, Feng L, Zhi L, Jiang D, Yu B, Zhang Z, Gao B, Zhang C, Li M, et al. 2021. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3. Carcinogenesis. 42:105–117.
   PubMed Web of Science ®Google Scholar